Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men''s and women''s hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand''s proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.